For a patient with mild‑to‑moderate generalized anxiety and no history of severe panic attacks, MAOI use, significant liver disease, or pregnancy, is buspirone an appropriate first‑line therapy?

Buspirone is NOT a good first-line choice for generalized anxiety

For a patient presenting with anxiety, SSRIs (specifically escitalopram or sertraline) should be your first-line pharmacotherapy, not buspirone. Multiple recent guidelines consistently prioritize SSRIs over buspirone for initial treatment of generalized anxiety disorder 1.

Why SSRIs Come First

The most recent and authoritative guidelines from 2023 establish a clear hierarchy:

• First-line: SSRIs (escitalopram, sertraline, fluvoxamine, paroxetine) 1
• Second-line: SNRIs (venlafaxine, duloxetine), pregabalin, or buspirone 1

The Japanese Society guidelines (2023) explicitly list escitalopram and sertraline as preferred first-line agents, relegating other SSRIs to second-line due to side effect profiles or discontinuation syndromes 1. This represents the most current expert consensus.

The Problem with Buspirone as First-Line

While buspirone is FDA-approved for GAD 2 and has a favorable safety profile, it has significant practical limitations:

• Delayed onset: Takes 2-4 weeks to become effective 3
• Limited efficacy: Only useful in mild-to-moderate agitation 3
• Weaker evidence base: Older efficacy studies were not performed using current GAD diagnostic criteria 4
• Lower priority in algorithms: Consistently ranked below SSRIs/SNRIs in treatment hierarchies 5, 6, 7

When Buspirone Makes Sense

Buspirone becomes a reasonable option in specific scenarios:

1. As a second-line agent after SSRI trial failure or intolerance 5, 6
2. When avoiding sexual side effects is critical in relatively healthy patients 6
3. In patients with substance abuse history where benzodiazepines are contraindicated 4
4. In elderly patients prioritizing avoidance of sexual dysfunction 6

Critical Safety Considerations

Before prescribing buspirone, verify:

• No concurrent MAOI use (absolute contraindication due to hypertensive crisis risk) 2
• No severe liver disease (requires dose adjustment)
• Not pregnant (limited safety data, though preliminary registry data show no malformations in 72 infants) 8
• Monitor for serotonin syndrome if combining with other serotonergic agents 2

The Practical Algorithm

Step 1: Start with escitalopram 10mg daily or sertraline 50mg daily 9

• Titrate slowly over 1-2 weeks for shorter half-life SSRIs
• Allow 4-8 weeks for full therapeutic trial 3, 9

Step 2: If inadequate response or intolerance, switch to:

• Different SSRI, OR
• SNRI (venlafaxine XR, duloxetine), OR
• Now consider buspirone 5mg twice daily, titrating to maximum 20mg three times daily 3, 2

Step 3: For third-line options, add pregabalin/gabapentin or quetiapine 6

Common Pitfall to Avoid

Do not start buspirone expecting rapid anxiety relief like benzodiazepines provide. Patients demanding immediate symptom control will be dissatisfied with buspirone's 2-4 week onset 10. Set realistic expectations: buspirone offers gradual improvement without dependency risk, but requires patience 10.

The evidence is clear: start with SSRIs, reserve buspirone for second-line treatment when first-line agents fail or specific patient factors (sexual dysfunction concerns, substance abuse history) make it preferable 5, 6, 7.